Ferumoxytol for iron deficiency anemia in children
Treatments studied
Part of Blood & lymphatic, Hormones & metabolism clinical trials.
This trial tests ferumoxytol, an intravenous iron medicine, to treat iron deficiency anemia in children who cannot take or did not respond well to iron by mouth. It aims to improve blood iron levels and anemia symptoms safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is 2 to under 18 years old
- Your child has iron deficiency anemia (low hemoglobin plus low iron measures like low transferrin saturation or ferritin)
- Oral iron treatment didn’t work well, wasn’t tolerated, or isn’t suitable for medical reasons
- Your child does not have a known allergy to ferumoxytol or to IV iron (including iron sucrose)
- Your child does not have kidney disease (low kidney filtering or need for ongoing dialysis)
- Your child does not have very low hemoglobin (7.0 g/dL or less) and ferritin is not extremely high (over 600 ng/mL)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two iron medicines—one a simple iron pill and the other a gentle iron form—to see which works better for children with low iron levels (anemia). If your child has iron deficiency anemia and none of the listed health issues, they may be able to join.
This study tests an iron injection for treating iron deficiency anemia. It checks how the medicine works in the body, and may help people whose blood iron is too low.
This trial tests whether a short course of intravenous (through a vein) iron called iron isomaltose can treat iron-deficiency anemia. It may help people who need faster iron replacement, but only if they meet key safety and health criteria.
This Phase 3 study compares taking iron through an IV versus by mouth to treat iron-deficiency anemia after Roux-en-Y gastric bypass or sleeve gastrectomy. The goal is to see which method works better and is safer for improving iron levels and blood counts.
This study compares two IV iron treatments—ferumoxytol and iron sucrose—to treat iron deficiency anemia in children with chronic kidney disease. It aims to see which option works better and is safe, and also to learn how each medicine behaves in the body.
This trial studies IV ferric derisomaltose to treat iron deficiency anemia in children under 18. It is meant for children whose anemia is from a true iron problem and who either cannot tolerate or do not respond to iron taken by mouth, or have certain kidney-related causes.
Hear when a new Iron Deficiency Anemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.